Somatostatin receptor scintigraphy before and after treatment with somatostatin analogues in patients with thyroid eye disease.

@article{Krassas1999SomatostatinRS,
  title={Somatostatin receptor scintigraphy before and after treatment with somatostatin analogues in patients with thyroid eye disease.},
  author={Gerasimos E. Krassas and Argyrios Doumas and Th. Kaltsas and A Halkias and Nikolaos Pontikides},
  journal={Thyroid : official journal of the American Thyroid Association},
  year={1999},
  volume={9 1},
  pages={47-52}
}
Octreotide, a potent synthetic long-acting somatostatin analogue, has been shown to have a beneficial effect in thyroid eye disease (TED). Orbital scintigraphy using ocetreoscan-111 is a useful study, which can be used to visualize somatostatin-receptor-bearing cells and also to select patients who might benefit from octreotide therapy. One major limitation of this therapy is that the drug must be administered parenterally and used several times daily. Lanreotide, a new somatostatin analogue… CONTINUE READING